CareLit · DOI-Nachweis · Zentralblatt für Gynäkologie
Gene Expression Profiles Predict Pathologic Complete Response to Preoperative Chemotherapy with Gemcitabine, Epirubicin and Docetaxel in Primary Breast Cancer
DOI 10.1055/s-2005-921007
Bibliografische Angaben
Nachweis in CareLit
Autor:innenA Schneeweiss, O Thuerigen, G Toedt, P Warnat, M Hahn, C Rudlowski, K Neben, A Benner, B Brors, R Eils, F Schuetz, D v Fournier, HP Sinn, G Bastert, C Sohn, P Lichter
ZeitschriftZentralblatt für Gynäkologie
Ausgabe10/2005
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Aims: While primary systemic therapy (PST) has gained considerable attention, it is impossible to predict sensitivity of primary breast cancer (PBC) to specific drugs. This study was designed to discover a gene expression profile that predicts pCR to PST with gemcitabine (G), epirubicin (E) and docetaxel (Doc) administered either as triple therapy (GEDoc) or sequentially (GE→Doc) for a total of 18 weeks. Patients an…
Zitieren
Zitierempfehlung
A Schneeweiss, O Thuerigen, G Toedt, P Warnat, M Hahn, C Rudlowski, K Neben, A Benner, B Brors, R Eils, F Schuetz, D v Fournier, HP Sinn, G Bastert, C Sohn, P Lichter (2005) Gene Expression Profiles Predict Pathologic Complete Response to Preoperative Chemotherapy with Gemcitabine, Epirubicin and Docetaxel in Primary Breast Cancer. Zentralblatt für Gynäkologie (10). https://doi.org/10.1055/s-2005-921007
Mit CareLit weiterarbeiten